Literature DB >> 22801676

What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation.

William J Catalona1, Anthony V D'Amico, William F Fitzgibbons, Omofolasade Kosoko-Lasaki, Stephen W Leslie, Henry T Lynch, Judd W Moul, Marc S Rendell, Patrick C Walsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22801676     DOI： 10.7326/0003-4819-157-2-201207170-00463

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  26 in total

1.  Prostate cancer: New PSA screening guideline faces widespread opposition.

Authors:  Sarah Payton
Journal:  Nat Rev Urol       Date:  2012-06-05       Impact factor: 14.432

2.  Prostate Cancer Screening and Management in Solid Organ Transplant Candidates and Recipients.

Authors:  Ezequiel Becher; Alex Wang; Herbert Lepor
Journal:  Rev Urol       Date:  2019

3.  Clarifying the positive association between education and prostate cancer: a Monte Carlo simulation approach.

Authors:  Tetyana Pudrovska; Andriy Anishkin
Journal:  J Appl Gerontol       Date:  2013-03-21

Review 4.  Prostate Cancer Screening.

Authors:  William J Catalona
Journal:  Med Clin North Am       Date:  2018-03       Impact factor: 5.456

5.  "Off-Label" Usage of Testicular Self-Examination (TSE): Benefits Beyond Cancer Detection.

Authors:  Michael J Rovito; James E Leone; Chase T Cavayero
Journal:  Am J Mens Health       Date:  2015-05-19

Review 6.  The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.

Authors:  Katherine Fleshner; Sigrid V Carlsson; Monique J Roobol
Journal:  Nat Rev Urol       Date:  2016-12-20       Impact factor: 14.432

Review 7.  More aggressive prostate cancer in elderly men.

Authors:  Annelies Vellekoop; Stacy Loeb
Journal:  Rev Urol       Date:  2013

8.  Five-year downstream outcomes following prostate-specific antigen screening in older men.

Authors:  Louise C Walter; Kathy Z Fung; Katharine A Kirby; Ying Shi; Roxanne Espaldon; Sarah O'Brien; Stephen J Freedland; Adam A Powell; Richard M Hoffman
Journal:  JAMA Intern Med       Date:  2013-05-27       Impact factor: 21.873

9.  [PSA screening 2013: background and perspectives].

Authors:  F Recker; D Seiler; B Seifert; M Randazzo; M Kwiatkowski
Journal:  Urologe A       Date:  2014-06       Impact factor: 0.639

10.  Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9.

Authors:  Eleftherios P Diamandis; Robert C Bast; Phil Gold; T Ming Chu; John L Magnani
Journal:  Clin Chem       Date:  2012-11-30       Impact factor: 8.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.